Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.0K
Cancer Vaccines01:30

Cancer Vaccines

581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Elevated prostate specific antigen due to indwelling urethral catheterisation: myth or fact? A systematic review and meta-analysis.

World journal of urology·2026
Same author

Artificial intelligence in urology: A review of United States Food and Drug Administration-cleared devices.

BJU international·2026
Same author

Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.

European radiology·2026
Same author

PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

Impact of comorbidity on patient reported outcome measures for men with localised prostate cancer.

BMC urology·2026
Same author

Reply to the Letter to the Editor: Variation in prostate cancer growth rates in an MRI-based active surveillance cohort.

European radiology·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
查看所有相关文章

相关实验视频

Updated: Oct 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K

前列腺癌

Shahneen Sandhu1, Caroline M Moore2, Edmund Chiong3

  • 1Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.

Lancet (London, England)
|August 9, 2021
PubMed
概括
此摘要是机器生成的。

前列腺癌管理的进步包括针对DNA修复途径的个性化治疗方法以及用于转移性疾病的新型雄激素抑制剂的改善生存率. 未来的研究重点是分子特征和放射性同位素和免疫疗法等新型治疗方法.

更多相关视频

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.6K

相关实验视频

Last Updated: Oct 25, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.4K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.6K

科学领域:

  • 癌症学
  • 生殖尿道癌症研究

背景情况:

  • 前列腺癌的治疗正在迅速发展.
  • 人们对基因组景观和生物学的理解有所进步.
  • 敏感的成像方法改善了诊断和分期.

研究的目的:

  • 审查前列腺癌管理的最新进展.
  • 突出个性化疗法和新型治疗策略的影响.
  • 讨论前列腺癌研究的未来方向.

主要方法:

  • 目前文献和临床实践的审查.
  • 基因组和分子特征数据的分析.
  • 评估新兴的治疗方法.

主要成果:

  • 针对DNA修复途径的个性化治疗方法得到了验证.
  • 以转移为导向的疗法对小转移性疾病具有前景.
  • 新型雄激素通路抑制剂显著提高了转移性前列腺癌的存活率.

结论:

  • 分子表征将影响局部和晚期疾病的临床管理.
  • 针对性放射性同位素和免疫疗法为未来的治疗提供了有前途的选择.
  • 持续的研究对于改善前列腺癌患者的治疗结果至关重要.